Role of FAN in tumor necrosis factor-alpha and lipopolysaccharide-induced interleukin-6 secretion and lethality in D-galactosamine-sensitized mice. 2004

Sophie Malagarie-Cazenave, and Bruno Ségui, and Sophie Lévêque, and Virginie Garcia, and Stéphane Carpentier, and Marie-Françoise Altié, and Anne Brouchet, and Valérie Gouazé, and Nathalie Andrieu-Abadie, and Yara Barreira, and Hervé Benoist, and Thierry Levade
INSERM U.466, Laboratoire de Biochimie, Institut Louis Bugnard, Centre Hospitalier Universitaire Rangueil, Toulouse, France.

Tumor necrosis factor (TNF) alpha-induced neutral sphingomyelinase-mediated generation of ceramide, a bioactive lipid molecule, is transduced by the adaptor protein FAN, which binds to the intracellular region of the CD120a TNFalpha receptor. FAN-deficient mice do not exhibit any gross abnormality. To further explore the functions of FAN in vivo and because CD120a-deficient mice are resistant to endotoxin-induced liver failure and lethality, we investigated the susceptibility of FAN-deficient animals to lipopolysaccharide (LPS). We show that after d-galactosamine sensitization, FAN-deficient mice were partially resistant to LPS- and TNFalpha-induced lethality. Although LPS challenge resulted in a hepatic ceramide content lower in mutant mice than in control animals, it triggered similar histological alterations, caspase activation, and DNA fragmentation in the liver. Interestingly, LPS-induced elevation of IL-6 (but not TNFalpha) serum concentrations was attenuated in FAN-deficient mice. A less pronounced secretion of IL-6 was also observed after LPS or TNFalpha treatment of cultured peritoneal macrophages and embryonic fibroblasts isolated from FAN-deficient mice, as well as in human fibroblasts expressing a mutated FAN. Finally, we show that d-galactosamine-sensitized IL-6-deficient mice were partially resistant to endotoxin-induced liver apoptosis and lethality. These findings highlight the role of FAN and IL-6 in the inflammatory response initiated by endotoxin, implicating TNFalpha.

UI MeSH Term Description Entries
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D011506 Proteins Linear POLYPEPTIDES that are synthesized on RIBOSOMES and may be further modified, crosslinked, cleaved, or assembled into complex proteins with several subunits. The specific sequence of AMINO ACIDS determines the shape the polypeptide will take, during PROTEIN FOLDING, and the function of the protein. Gene Products, Protein,Gene Proteins,Protein,Protein Gene Products,Proteins, Gene
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002518 Ceramides Members of the class of neutral glycosphingolipids. They are the basic units of SPHINGOLIPIDS. They are sphingoids attached via their amino groups to a long chain fatty acyl group. They abnormally accumulate in FABRY DISEASE. Ceramide
D004351 Drug Resistance Diminished or failed response of an organism, disease or tissue to the intended effectiveness of a chemical or drug. It should be differentiated from DRUG TOLERANCE which is the progressive diminution of the susceptibility of a human or animal to the effects of a drug, as a result of continued administration. Resistance, Drug
D005347 Fibroblasts Connective tissue cells which secrete an extracellular matrix rich in collagen and other macromolecules. Fibroblast
D005688 Galactosamine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Sophie Malagarie-Cazenave, and Bruno Ségui, and Sophie Lévêque, and Virginie Garcia, and Stéphane Carpentier, and Marie-Françoise Altié, and Anne Brouchet, and Valérie Gouazé, and Nathalie Andrieu-Abadie, and Yara Barreira, and Hervé Benoist, and Thierry Levade
January 1991, Immunopharmacology and immunotoxicology,
Sophie Malagarie-Cazenave, and Bruno Ségui, and Sophie Lévêque, and Virginie Garcia, and Stéphane Carpentier, and Marie-Françoise Altié, and Anne Brouchet, and Valérie Gouazé, and Nathalie Andrieu-Abadie, and Yara Barreira, and Hervé Benoist, and Thierry Levade
May 1996, Infection and immunity,
Sophie Malagarie-Cazenave, and Bruno Ségui, and Sophie Lévêque, and Virginie Garcia, and Stéphane Carpentier, and Marie-Françoise Altié, and Anne Brouchet, and Valérie Gouazé, and Nathalie Andrieu-Abadie, and Yara Barreira, and Hervé Benoist, and Thierry Levade
September 1996, Gastroenterology,
Sophie Malagarie-Cazenave, and Bruno Ségui, and Sophie Lévêque, and Virginie Garcia, and Stéphane Carpentier, and Marie-Françoise Altié, and Anne Brouchet, and Valérie Gouazé, and Nathalie Andrieu-Abadie, and Yara Barreira, and Hervé Benoist, and Thierry Levade
October 1995, European journal of immunology,
Sophie Malagarie-Cazenave, and Bruno Ségui, and Sophie Lévêque, and Virginie Garcia, and Stéphane Carpentier, and Marie-Françoise Altié, and Anne Brouchet, and Valérie Gouazé, and Nathalie Andrieu-Abadie, and Yara Barreira, and Hervé Benoist, and Thierry Levade
October 2001, Liver,
Sophie Malagarie-Cazenave, and Bruno Ségui, and Sophie Lévêque, and Virginie Garcia, and Stéphane Carpentier, and Marie-Françoise Altié, and Anne Brouchet, and Valérie Gouazé, and Nathalie Andrieu-Abadie, and Yara Barreira, and Hervé Benoist, and Thierry Levade
February 1991, The Journal of experimental medicine,
Sophie Malagarie-Cazenave, and Bruno Ségui, and Sophie Lévêque, and Virginie Garcia, and Stéphane Carpentier, and Marie-Françoise Altié, and Anne Brouchet, and Valérie Gouazé, and Nathalie Andrieu-Abadie, and Yara Barreira, and Hervé Benoist, and Thierry Levade
November 1999, Journal of hepatology,
Sophie Malagarie-Cazenave, and Bruno Ségui, and Sophie Lévêque, and Virginie Garcia, and Stéphane Carpentier, and Marie-Françoise Altié, and Anne Brouchet, and Valérie Gouazé, and Nathalie Andrieu-Abadie, and Yara Barreira, and Hervé Benoist, and Thierry Levade
April 2008, Cytokine,
Sophie Malagarie-Cazenave, and Bruno Ségui, and Sophie Lévêque, and Virginie Garcia, and Stéphane Carpentier, and Marie-Françoise Altié, and Anne Brouchet, and Valérie Gouazé, and Nathalie Andrieu-Abadie, and Yara Barreira, and Hervé Benoist, and Thierry Levade
September 1994, European journal of immunology,
Sophie Malagarie-Cazenave, and Bruno Ségui, and Sophie Lévêque, and Virginie Garcia, and Stéphane Carpentier, and Marie-Françoise Altié, and Anne Brouchet, and Valérie Gouazé, and Nathalie Andrieu-Abadie, and Yara Barreira, and Hervé Benoist, and Thierry Levade
March 1987, The Journal of experimental medicine,
Copied contents to your clipboard!